SEP 24, 2020 7:30 AM PDT

2-In-1: Stroke Scans Also Diagnose COVID

WRITTEN BY: Tara Fernandez

King’s College London researchers took a closer look at emergency room CT scans of patients suspected of having a stroke and made a surprising discovery: the scans could also be used to indicate the presence of COVID-19 infection.

The study, published in the American Journal of Neuroradiology saw the researchers examining over 200 carotid CTA scans of the blood vessels in the head and neck of patients who were admitted to the stroke unit.

They noticed that in around 20 percent of the scans, the upper regions of the lungs showed ground glass opacity or GGO. This is a term used in radiology to describe the slightly hazy opacity in the respiratory system, indicating that the air spaces in the lungs have partially filled up with fluid.

When put side by side with the COVID-19 diagnostic tests, the authors found that the presence of GGO in CT scans was a solid diagnostic marker of infection, with 75 percent sensitivity and 81 percent specificity. GGO in the lungs was also found to spell bad news for patients, spiking their risk of mortality in the month following the find.

According to the team, this serendipitous finding can limit avoidable exposures of hospital staff to infected patients.

“The implications of our findings plausibly include the earlier selection of the appropriate level of personal protective equipment and attendant staff numbers, triage to appropriate inpatient ward settings, self-isolation, and contact tracing,” the team explained. 

“Biomarkers, such as a scan positive for GGO, should heighten awareness of a potential positive case, possibly changing staff personal protective equipment requirements and also directing a patient to a side room instead of an open ward, pending RT-PCR results.”

 

 

Sources: Diagnostic Imaging, American Journal of Neuroradiology.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
MAY 06, 2021
Clinical & Molecular DX
Sweat Sensor Can Tell If a Storm's Coming
MAY 06, 2021
Sweat Sensor Can Tell If a Storm's Coming
A surge of pro-inflammatory cytokines, intense, and sustained inflammation leading to organ damage and a high risk of de ...
MAY 18, 2021
Genetics & Genomics
Library Prep Methods for SARS-CoV-2 Sequencing: a Summary
MAY 18, 2021
Library Prep Methods for SARS-CoV-2 Sequencing: a Summary
As the SARS-CoV-2 virus continues to mutate, rapid sequencing of COVID-19-positive samples is more critical than ever. N ...
MAY 13, 2021
Clinical & Molecular DX
Smart Patch Measures How Itchy You Are
MAY 13, 2021
Smart Patch Measures How Itchy You Are
A wearable “scratch sensor” developed by researchers at Northwestern University could finally help doctors m ...
MAY 26, 2021
Genetics & Genomics
Connecting Bacterial Genes to Human Disease
MAY 26, 2021
Connecting Bacterial Genes to Human Disease
This kind of research gets us closer to using fecal samples to get a snapshot of the microbiome, and make disease risk p ...
SEP 21, 2021
Clinical & Molecular DX
Kidney Failure in COVID Survivors
SEP 21, 2021
Kidney Failure in COVID Survivors
New findings indicate that individuals who survive COVID-19 infections, even mild ones, have a significantly elevated ri ...
SEP 28, 2021
Clinical & Molecular DX
Black College Football Players More at Risk of Heart Conditions
SEP 28, 2021
Black College Football Players More at Risk of Heart Conditions
College football players may have an elevated risk of developing a heart condition where the left side of the heart beco ...
Loading Comments...